US Federal Appeal Court upholds Myriad Gene patent
By guest blogger Doug Calhoun for sticK
(sticK - 21 August 2012 ) A US appeals court has for a second time upheld the validity of the Myriad Genetics gene patent. In its 16 August 2012 decision.
The same judges again decided 2 to 1 in favour of Myriad for the same reasons as in their July 2011 decision. Each of the judges expanded on her or his reasoning, but their conclusions remained unchanged.
Click to read the rest of this story
For sticK – science, technology, innovation & commercialisation KNOWLEDGE - is a new Wellington based news service concentrating on following the money from ideas to income. Contact editor Peter Kerr at peter.kerr055 @ gmail.com

Bill Bennett: Fixed Voice Rules Head For Deregulation
UN Department of Global Communications: United Nations Proposes New Global Dashboard To Measure Progress Beyond GDP
Banking Ombudsman Scheme: Fraud Check Delays Well Worth The Inconvenience, Says Banking Ombudsman
Asia Pacific AML: NZ’s Financial Crime Gap - Beyond The 'Number 8 Wire' Mentality
Westpac New Zealand: Kiwi Households Adapting Despite Widespread Cost Pressure Concerns, Westpac Survey Shows
University of Auckland: Kids’ Screen Use Linked To Long-Term Deficits In Self-Control And Attention

